BioSig Technologies Stock Price, News & Analysis

BioSig Technologies, Inc., formerly known by the ticker symbol BSGM on the Nasdaq Capital Market, has undergone a significant corporate transformation and rebranding. According to company disclosures, BioSig merged with Streamex Exchange Corporation and subsequently changed its corporate name to Streamex Corp. and its trading symbol to STEX. As a result, the BSGM symbol now represents the historical identity of the company, while ongoing trading, filings, and market information are reported under the STEX symbol.

Historically, BioSig Technologies was described as a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform. This platform was designed to deliver insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. Company materials explain that the PURE EP Platform enables electrophysiologists to acquire raw signal data in real time, with the goal of reducing unnecessary noise or interference and supporting procedural success and efficiency in the electrophysiology lab.

Following the merger with Streamex Exchange Corporation, the combined organization shifted its strategic focus toward real-world asset (RWA) tokenization and gold-related financial infrastructure. Streamex is described in company press releases and SEC filings as a gold tokenization and gold treasury business building institutional-grade infrastructure to bring the gold and broader commodities markets on chain. Disclosures note that Streamex is developing a vertically integrated platform that combines token issuance, trading infrastructure, and physical gold holdings, with an emphasis on gold-backed and commodity-backed digital assets.

Company communications state that Streamex is a wholly owned subsidiary of the former BioSig Technologies, Inc., and that the merged entity is pursuing a strategy centered on tokenized, yield-bearing gold products and on-chain commodity markets. This includes partnerships and agreements aimed at integrating tokenized gold into regulated investment products and using a gold-denominated treasury and tokenization technology to support new types of digital assets.

For investors researching the historical BSGM listing, it is important to recognize that:

• The corporate name was changed from BioSig Technologies, Inc. to Streamex Corp. by amendment to the certificate of incorporation.
• The Nasdaq ticker symbol was changed from BSGM to STEX, with company statements indicating that trading and filings would continue under the new symbol.
• The business profile expanded from a focus on medical device technology and the PURE EP Platform to include, and ultimately center on, RWA and gold tokenization infrastructure through Streamex.

According to SEC filings, the company has also undertaken various capital markets and strategic transactions in support of this new direction. These include a secured convertible debenture purchase agreement with an institutional investor, a public offering of common stock to fund gold bullion purchases under an investment policy, and corporate governance changes such as amendments to its certificate of incorporation and long-term incentive plans. The company has also reported entering into a tokenized yield partnership agreement related to precious-metal lease and bond programs, and acquiring an equity interest in a royalty and streaming company to gain exposure to gold and silver royalty and streaming assets.

In addition, Streamex Corp. has described plans and actions toward operating as a regulated participant in tokenized real-world asset markets, including engaging a specialist firm to manage the acquisition of a FINRA and SEC-registered broker-dealer. Company disclosures explain that this is intended to support issuance and trading of regulated, gold-backed tokenized investment opportunities on a major U.S. exchange.

While the BSGM symbol is no longer the active trading symbol, it remains relevant for understanding the company’s evolution from a medical device technology issuer to a gold tokenization and RWA-focused enterprise now operating as Streamex Corp. under the STEX ticker.